FDA inspection
Cambrex Profarmaco Milano Srl: FDA inspection ending Nov 11, 2022
FDA inspection 1193220 · No Action Indicated (NAI) · Paullo
Key facts
| Inspection ID | 1193220 |
|---|---|
| Firm | Cambrex Profarmaco Milano Srl |
| FEI number | 3003723076 |
| Address | Via Eugenio Curiel 34 |
| City | Paullo |
| Country | Italy |
| Fiscal year | 2023 |
| Inspection end date | Nov 11, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data